Clinical Trial: Efficacy of Treatment Strategies for SID- a Comparison of Insulin Therapy and FRC Therapy (Insulin + GLP-1 Receptor Agonist)

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07117240) titled 'Efficacy of Treatment Strategies for SID- a Comparison of Insulin Therapy and FRC Therapy (Insulin + GLP-1 Receptor Agonist)' on July 28.

Brief Summary: Glucocorticoids are commonly used in the treatment of autoimmune, inflammatory, and neoplastic diseases. Despite their therapeutic efficacy, they are associated with significant metabolic side effects. In the proposed research, the aim is to assess the metabolic efficacy and safety of fixed-ratio combination therapy (basal insulin + GLP-1 receptor agonist) compared to standard insulin therapy in patients with SID. In a selected group of patients, a randomised clinical trial would be...